CN113355346A - 删除稳定载体上冗余片段的方法,采用该方法得到的稳定载体及其应用 - Google Patents
删除稳定载体上冗余片段的方法,采用该方法得到的稳定载体及其应用 Download PDFInfo
- Publication number
- CN113355346A CN113355346A CN202010850010.XA CN202010850010A CN113355346A CN 113355346 A CN113355346 A CN 113355346A CN 202010850010 A CN202010850010 A CN 202010850010A CN 113355346 A CN113355346 A CN 113355346A
- Authority
- CN
- China
- Prior art keywords
- recombinase
- stable
- vector
- plasmid
- resistance gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000013598 vector Substances 0.000 title claims abstract description 64
- 238000000034 method Methods 0.000 title claims abstract description 36
- 108010091086 Recombinases Proteins 0.000 claims abstract description 64
- 102000018120 Recombinases Human genes 0.000 claims abstract description 64
- 239000013612 plasmid Substances 0.000 claims abstract description 63
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 54
- 239000012634 fragment Substances 0.000 claims abstract description 51
- 239000002773 nucleotide Substances 0.000 claims abstract description 9
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 9
- 101150035521 parS gene Proteins 0.000 claims abstract description 5
- 101710087869 Replication protein RepA Proteins 0.000 claims abstract description 4
- 238000011144 upstream manufacturing Methods 0.000 claims abstract description 4
- 101100278012 Escherichia coli (strain K12) dnaG gene Proteins 0.000 claims abstract description 3
- 101100165173 Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720) basS gene Proteins 0.000 claims abstract description 3
- 101100421924 Thermus thermophilus (strain ATCC BAA-163 / DSM 7039 / HB27) spo0C gene Proteins 0.000 claims abstract description 3
- 101150004979 flmA gene Proteins 0.000 claims abstract description 3
- 101150048892 parB gene Proteins 0.000 claims abstract description 3
- 230000006641 stabilisation Effects 0.000 claims abstract 2
- 238000011105 stabilization Methods 0.000 claims abstract 2
- 229930027917 kanamycin Natural products 0.000 claims description 31
- 229960000318 kanamycin Drugs 0.000 claims description 31
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 claims description 31
- 229930182823 kanamycin A Natural products 0.000 claims description 31
- 241000481518 Ralstonia eutropha H16 Species 0.000 claims description 24
- 241000588724 Escherichia coli Species 0.000 claims description 13
- 241000894006 Bacteria Species 0.000 claims description 10
- 230000003115 biocidal effect Effects 0.000 claims description 10
- 239000003242 anti bacterial agent Substances 0.000 claims description 7
- 238000010353 genetic engineering Methods 0.000 claims description 4
- 230000006798 recombination Effects 0.000 claims description 3
- 238000005215 recombination Methods 0.000 claims description 3
- 108010051219 Cre recombinase Proteins 0.000 claims description 2
- 108010046276 FLP recombinase Proteins 0.000 claims description 2
- 102100024370 Integrator complex subunit 11 Human genes 0.000 claims description 2
- 101710149806 Integrator complex subunit 11 Proteins 0.000 claims description 2
- 102100037944 Integrator complex subunit 12 Human genes 0.000 claims description 2
- 101710149803 Integrator complex subunit 12 Proteins 0.000 claims description 2
- 102100033263 Integrator complex subunit 3 Human genes 0.000 claims description 2
- 101710092886 Integrator complex subunit 3 Proteins 0.000 claims description 2
- 102100039134 Integrator complex subunit 4 Human genes 0.000 claims description 2
- 101710092887 Integrator complex subunit 4 Proteins 0.000 claims description 2
- 102100039131 Integrator complex subunit 5 Human genes 0.000 claims description 2
- 101710092888 Integrator complex subunit 5 Proteins 0.000 claims description 2
- 102100030206 Integrator complex subunit 9 Human genes 0.000 claims description 2
- 101710092893 Integrator complex subunit 9 Proteins 0.000 claims description 2
- 238000012217 deletion Methods 0.000 abstract description 7
- 230000037430 deletion Effects 0.000 abstract description 7
- 108020004414 DNA Proteins 0.000 description 30
- 239000005090 green fluorescent protein Substances 0.000 description 21
- 230000014759 maintenance of location Effects 0.000 description 13
- 241000186394 Eubacterium Species 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 10
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 7
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 description 7
- 229920000903 polyhydroxyalkanoate Polymers 0.000 description 7
- 238000012546 transfer Methods 0.000 description 7
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 239000013600 plasmid vector Substances 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000000087 stabilizing effect Effects 0.000 description 5
- 241001528539 Cupriavidus necator Species 0.000 description 4
- 230000004543 DNA replication Effects 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- JBDLMLZNDRLDIX-HJGDQZAQSA-N Asn-Thr-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O JBDLMLZNDRLDIX-HJGDQZAQSA-N 0.000 description 3
- 150000001413 amino acids Chemical group 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 238000009776 industrial production Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 2
- YAALVYQFVJNXIV-KKUMJFAQSA-N His-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CN=CN1 YAALVYQFVJNXIV-KKUMJFAQSA-N 0.000 description 2
- 102100034343 Integrase Human genes 0.000 description 2
- 108010061833 Integrases Proteins 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 101710150114 Protein rep Proteins 0.000 description 2
- 241000232299 Ralstonia Species 0.000 description 2
- 101710152114 Replication protein Proteins 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- 108010052160 Site-specific recombinase Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- XPKCFQZDQGVJCX-RHYQMDGZSA-N Val-Lys-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C(C)C)N)O XPKCFQZDQGVJCX-RHYQMDGZSA-N 0.000 description 2
- 108010070944 alanylhistidine Proteins 0.000 description 2
- XZNUGFQTQHRASN-XQENGBIVSA-N apramycin Chemical compound O([C@H]1O[C@@H]2[C@H](O)[C@@H]([C@H](O[C@H]2C[C@H]1N)O[C@@H]1[C@@H]([C@@H](O)[C@H](N)[C@@H](CO)O1)O)NC)[C@@H]1[C@@H](N)C[C@@H](N)[C@H](O)[C@H]1O XZNUGFQTQHRASN-XQENGBIVSA-N 0.000 description 2
- 229950006334 apramycin Drugs 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 2
- 108010050848 glycylleucine Proteins 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 108010034529 leucyl-lysine Proteins 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 210000003370 receptor cell Anatomy 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 229960000268 spectinomycin Drugs 0.000 description 2
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 2
- 238000011426 transformation method Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- JNTMAZFVYNDPLB-PEDHHIEDSA-N (2S,3S)-2-[[[(2S)-1-[(2S,3S)-2-amino-3-methyl-1-oxopentyl]-2-pyrrolidinyl]-oxomethyl]amino]-3-methylpentanoic acid Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JNTMAZFVYNDPLB-PEDHHIEDSA-N 0.000 description 1
- BUANFPRKJKJSRR-ACZMJKKPSA-N Ala-Ala-Gln Chemical compound C[C@H]([NH3+])C(=O)N[C@@H](C)C(=O)N[C@H](C([O-])=O)CCC(N)=O BUANFPRKJKJSRR-ACZMJKKPSA-N 0.000 description 1
- LWUWMHIOBPTZBA-DCAQKATOSA-N Ala-Arg-Lys Chemical compound NC(=N)NCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CCCCN)C(O)=O LWUWMHIOBPTZBA-DCAQKATOSA-N 0.000 description 1
- NKJBKNVQHBZUIX-ACZMJKKPSA-N Ala-Gln-Asp Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O NKJBKNVQHBZUIX-ACZMJKKPSA-N 0.000 description 1
- WKOBSJOZRJJVRZ-FXQIFTODSA-N Ala-Glu-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O WKOBSJOZRJJVRZ-FXQIFTODSA-N 0.000 description 1
- LJFNNUBZSZCZFN-WHFBIAKZSA-N Ala-Gly-Cys Chemical compound N[C@@H](C)C(=O)NCC(=O)N[C@@H](CS)C(=O)O LJFNNUBZSZCZFN-WHFBIAKZSA-N 0.000 description 1
- BLIMFWGRQKRCGT-YUMQZZPRSA-N Ala-Gly-Lys Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCCN BLIMFWGRQKRCGT-YUMQZZPRSA-N 0.000 description 1
- GSHKMNKPMLXSQW-KBIXCLLPSA-N Ala-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](C)N GSHKMNKPMLXSQW-KBIXCLLPSA-N 0.000 description 1
- XUCHENWTTBFODJ-FXQIFTODSA-N Ala-Met-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(O)=O XUCHENWTTBFODJ-FXQIFTODSA-N 0.000 description 1
- CNQAFFMNJIQYGX-DRZSPHRISA-N Ala-Phe-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 CNQAFFMNJIQYGX-DRZSPHRISA-N 0.000 description 1
- NZGRHTKZFSVPAN-BIIVOSGPSA-N Ala-Ser-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N NZGRHTKZFSVPAN-BIIVOSGPSA-N 0.000 description 1
- QOIGKCBMXUCDQU-KDXUFGMBSA-N Ala-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C)N)O QOIGKCBMXUCDQU-KDXUFGMBSA-N 0.000 description 1
- KMSHNDWHPWXPEC-BQBZGAKWSA-N Arg-Asp-Gly Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O KMSHNDWHPWXPEC-BQBZGAKWSA-N 0.000 description 1
- JUWQNWXEGDYCIE-YUMQZZPRSA-N Arg-Gln-Gly Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O JUWQNWXEGDYCIE-YUMQZZPRSA-N 0.000 description 1
- OTZMRMHZCMZOJZ-SRVKXCTJSA-N Arg-Leu-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O OTZMRMHZCMZOJZ-SRVKXCTJSA-N 0.000 description 1
- VYZBPPBKFCHCIS-WPRPVWTQSA-N Arg-Val-Gly Chemical compound OC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCN=C(N)N VYZBPPBKFCHCIS-WPRPVWTQSA-N 0.000 description 1
- WPOLSNAQGVHROR-GUBZILKMSA-N Asn-Gln-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)N)N WPOLSNAQGVHROR-GUBZILKMSA-N 0.000 description 1
- COUZKSSMBFADSB-AVGNSLFASA-N Asn-Glu-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)N)N COUZKSSMBFADSB-AVGNSLFASA-N 0.000 description 1
- GOPFMQJUQDLUFW-LKXGYXEUSA-N Asn-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O GOPFMQJUQDLUFW-LKXGYXEUSA-N 0.000 description 1
- CBWCQCANJSGUOH-ZKWXMUAHSA-N Asn-Val-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O CBWCQCANJSGUOH-ZKWXMUAHSA-N 0.000 description 1
- IXIWEFWRKIUMQX-DCAQKATOSA-N Asp-Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O IXIWEFWRKIUMQX-DCAQKATOSA-N 0.000 description 1
- GKWFMNNNYZHJHV-SRVKXCTJSA-N Asp-Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(O)=O GKWFMNNNYZHJHV-SRVKXCTJSA-N 0.000 description 1
- ITGFVUYOLWBPQW-KKHAAJSZSA-N Asp-Thr-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O ITGFVUYOLWBPQW-KKHAAJSZSA-N 0.000 description 1
- 241001528480 Cupriavidus Species 0.000 description 1
- OXFOKRAFNYSREH-BJDJZHNGSA-N Cys-Ile-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CS)N OXFOKRAFNYSREH-BJDJZHNGSA-N 0.000 description 1
- KXUKWRVYDYIPSQ-CIUDSAMLSA-N Cys-Leu-Ala Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O KXUKWRVYDYIPSQ-CIUDSAMLSA-N 0.000 description 1
- 238000012270 DNA recombination Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 101150066002 GFP gene Proteins 0.000 description 1
- GQZDDFRXSDGUNG-YVNDNENWSA-N Gln-Ile-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(O)=O GQZDDFRXSDGUNG-YVNDNENWSA-N 0.000 description 1
- JUUNNOLZGVYCJT-JYJNAYRXSA-N Gln-Phe-Lys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)N)N JUUNNOLZGVYCJT-JYJNAYRXSA-N 0.000 description 1
- ININBLZFFVOQIO-JHEQGTHGSA-N Gln-Thr-Gly Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCC(=O)N)N)O ININBLZFFVOQIO-JHEQGTHGSA-N 0.000 description 1
- ATRHMOJQJWPVBQ-DRZSPHRISA-N Glu-Ala-Phe Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ATRHMOJQJWPVBQ-DRZSPHRISA-N 0.000 description 1
- YYOBUPFZLKQUAX-FXQIFTODSA-N Glu-Asn-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O YYOBUPFZLKQUAX-FXQIFTODSA-N 0.000 description 1
- ILGFBUGLBSAQQB-GUBZILKMSA-N Glu-Glu-Arg Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O ILGFBUGLBSAQQB-GUBZILKMSA-N 0.000 description 1
- CUPSDFQZTVVTSK-GUBZILKMSA-N Glu-Lys-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(O)=O CUPSDFQZTVVTSK-GUBZILKMSA-N 0.000 description 1
- VIPDPMHGICREIS-GVXVVHGQSA-N Glu-Val-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O VIPDPMHGICREIS-GVXVVHGQSA-N 0.000 description 1
- PHONXOACARQMPM-BQBZGAKWSA-N Gly-Ala-Met Chemical compound [H]NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(O)=O PHONXOACARQMPM-BQBZGAKWSA-N 0.000 description 1
- RPLLQZBOVIVGMX-QWRGUYRKSA-N Gly-Asp-Phe Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O RPLLQZBOVIVGMX-QWRGUYRKSA-N 0.000 description 1
- MOJKRXIRAZPZLW-WDSKDSINSA-N Gly-Glu-Ala Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O MOJKRXIRAZPZLW-WDSKDSINSA-N 0.000 description 1
- LOEANKRDMMVOGZ-YUMQZZPRSA-N Gly-Lys-Asp Chemical compound NCCCC[C@H](NC(=O)CN)C(=O)N[C@@H](CC(O)=O)C(O)=O LOEANKRDMMVOGZ-YUMQZZPRSA-N 0.000 description 1
- FFJQHWKSGAWSTJ-BFHQHQDPSA-N Gly-Thr-Ala Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O FFJQHWKSGAWSTJ-BFHQHQDPSA-N 0.000 description 1
- BNMRSWQOHIQTFL-JSGCOSHPSA-N Gly-Val-Phe Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 BNMRSWQOHIQTFL-JSGCOSHPSA-N 0.000 description 1
- IDNNYVGVSZMQTK-IHRRRGAJSA-N His-Arg-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N IDNNYVGVSZMQTK-IHRRRGAJSA-N 0.000 description 1
- TTZAWSKKNCEINZ-AVGNSLFASA-N His-Arg-Val Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O TTZAWSKKNCEINZ-AVGNSLFASA-N 0.000 description 1
- TTYKEFZRLKQTHH-MELADBBJSA-N His-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CN=CN2)N)C(=O)O TTYKEFZRLKQTHH-MELADBBJSA-N 0.000 description 1
- KAXZXLSXFWSNNZ-XVYDVKMFSA-N His-Ser-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O KAXZXLSXFWSNNZ-XVYDVKMFSA-N 0.000 description 1
- FHKZHRMERJUXRJ-DCAQKATOSA-N His-Ser-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CN=CN1 FHKZHRMERJUXRJ-DCAQKATOSA-N 0.000 description 1
- JDAWAWXGAUZPNJ-ZPFDUUQYSA-N Ile-Glu-Arg Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N JDAWAWXGAUZPNJ-ZPFDUUQYSA-N 0.000 description 1
- KLBVGHCGHUNHEA-BJDJZHNGSA-N Ile-Leu-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)N KLBVGHCGHUNHEA-BJDJZHNGSA-N 0.000 description 1
- PHRWFSFCNJPWRO-PPCPHDFISA-N Ile-Leu-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N PHRWFSFCNJPWRO-PPCPHDFISA-N 0.000 description 1
- GLYJPWIRLBAIJH-FQUUOJAGSA-N Ile-Lys-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@@H]1C(=O)O)N GLYJPWIRLBAIJH-FQUUOJAGSA-N 0.000 description 1
- GLYJPWIRLBAIJH-UHFFFAOYSA-N Ile-Lys-Pro Natural products CCC(C)C(N)C(=O)NC(CCCCN)C(=O)N1CCCC1C(O)=O GLYJPWIRLBAIJH-UHFFFAOYSA-N 0.000 description 1
- NURNJECQNNCRBK-FLBSBUHZSA-N Ile-Thr-Thr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O NURNJECQNNCRBK-FLBSBUHZSA-N 0.000 description 1
- SITWEMZOJNKJCH-UHFFFAOYSA-N L-alanine-L-arginine Natural products CC(N)C(=O)NC(C(O)=O)CCCNC(N)=N SITWEMZOJNKJCH-UHFFFAOYSA-N 0.000 description 1
- KTFHTMHHKXUYPW-ZPFDUUQYSA-N Leu-Asp-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KTFHTMHHKXUYPW-ZPFDUUQYSA-N 0.000 description 1
- DLCOFDAHNMMQPP-SRVKXCTJSA-N Leu-Asp-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DLCOFDAHNMMQPP-SRVKXCTJSA-N 0.000 description 1
- XVSJMWYYLHPDKY-DCAQKATOSA-N Leu-Asp-Met Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(O)=O XVSJMWYYLHPDKY-DCAQKATOSA-N 0.000 description 1
- VZBIUJURDLFFOE-IHRRRGAJSA-N Leu-His-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O VZBIUJURDLFFOE-IHRRRGAJSA-N 0.000 description 1
- LXKNSJLSGPNHSK-KKUMJFAQSA-N Leu-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N LXKNSJLSGPNHSK-KKUMJFAQSA-N 0.000 description 1
- WXZOHBVPVKABQN-DCAQKATOSA-N Leu-Met-Asp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)O)N WXZOHBVPVKABQN-DCAQKATOSA-N 0.000 description 1
- NFLFJGGKOHYZJF-BJDJZHNGSA-N Lys-Ala-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN NFLFJGGKOHYZJF-BJDJZHNGSA-N 0.000 description 1
- LMVOVCYVZBBWQB-SRVKXCTJSA-N Lys-Asp-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN LMVOVCYVZBBWQB-SRVKXCTJSA-N 0.000 description 1
- NNKLKUUGESXCBS-KBPBESRZSA-N Lys-Gly-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O NNKLKUUGESXCBS-KBPBESRZSA-N 0.000 description 1
- OIQSIMFSVLLWBX-VOAKCMCISA-N Lys-Leu-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OIQSIMFSVLLWBX-VOAKCMCISA-N 0.000 description 1
- ZJWIXBZTAAJERF-IHRRRGAJSA-N Lys-Lys-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CCCN=C(N)N ZJWIXBZTAAJERF-IHRRRGAJSA-N 0.000 description 1
- YUAXTFMFMOIMAM-QWRGUYRKSA-N Lys-Lys-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O YUAXTFMFMOIMAM-QWRGUYRKSA-N 0.000 description 1
- IECZNARPMKQGJC-XIRDDKMYSA-N Met-Gln-Trp Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N IECZNARPMKQGJC-XIRDDKMYSA-N 0.000 description 1
- QGRJTULYDZUBAY-ZPFDUUQYSA-N Met-Ile-Glu Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O QGRJTULYDZUBAY-ZPFDUUQYSA-N 0.000 description 1
- WUGMRIBZSVSJNP-UHFFFAOYSA-N N-L-alanyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)C)C(O)=O)=CNC2=C1 WUGMRIBZSVSJNP-UHFFFAOYSA-N 0.000 description 1
- 108010079364 N-glycylalanine Proteins 0.000 description 1
- 241000498271 Necator Species 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- KIAWKQJTSGRCSA-AVGNSLFASA-N Phe-Asn-Glu Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N KIAWKQJTSGRCSA-AVGNSLFASA-N 0.000 description 1
- MSHZERMPZKCODG-ACRUOGEOSA-N Phe-Leu-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 MSHZERMPZKCODG-ACRUOGEOSA-N 0.000 description 1
- GMWNQSGWWGKTSF-LFSVMHDDSA-N Phe-Thr-Ala Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O GMWNQSGWWGKTSF-LFSVMHDDSA-N 0.000 description 1
- ILMLVTGTUJPQFP-FXQIFTODSA-N Pro-Asp-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O ILMLVTGTUJPQFP-FXQIFTODSA-N 0.000 description 1
- YFNOUBWUIIJQHF-LPEHRKFASA-N Pro-Asp-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC(=O)O)C(=O)N2CCC[C@@H]2C(=O)O YFNOUBWUIIJQHF-LPEHRKFASA-N 0.000 description 1
- SFECXGVELZFBFJ-VEVYYDQMSA-N Pro-Asp-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SFECXGVELZFBFJ-VEVYYDQMSA-N 0.000 description 1
- 108090000951 RNA polymerase sigma 70 Proteins 0.000 description 1
- 101710088839 Replication initiation protein Proteins 0.000 description 1
- BRKHVZNDAOMAHX-BIIVOSGPSA-N Ser-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N BRKHVZNDAOMAHX-BIIVOSGPSA-N 0.000 description 1
- IDCKUIWEIZYVSO-WFBYXXMGSA-N Ser-Ala-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C)C(O)=O)=CNC2=C1 IDCKUIWEIZYVSO-WFBYXXMGSA-N 0.000 description 1
- HBOABDXGTMMDSE-GUBZILKMSA-N Ser-Arg-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O HBOABDXGTMMDSE-GUBZILKMSA-N 0.000 description 1
- ULVMNZOKDBHKKI-ACZMJKKPSA-N Ser-Gln-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O ULVMNZOKDBHKKI-ACZMJKKPSA-N 0.000 description 1
- AEGUWTFAQQWVLC-BQBZGAKWSA-N Ser-Gly-Arg Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O AEGUWTFAQQWVLC-BQBZGAKWSA-N 0.000 description 1
- MIJWOJAXARLEHA-WDSKDSINSA-N Ser-Gly-Glu Chemical compound OC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(O)=O MIJWOJAXARLEHA-WDSKDSINSA-N 0.000 description 1
- XXXAXOWMBOKTRN-XPUUQOCRSA-N Ser-Gly-Val Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O XXXAXOWMBOKTRN-XPUUQOCRSA-N 0.000 description 1
- VMLONWHIORGALA-SRVKXCTJSA-N Ser-Leu-Leu Chemical compound CC(C)C[C@@H](C([O-])=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CO VMLONWHIORGALA-SRVKXCTJSA-N 0.000 description 1
- KCGIREHVWRXNDH-GARJFASQSA-N Ser-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N KCGIREHVWRXNDH-GARJFASQSA-N 0.000 description 1
- GVIGVIOEYBOTCB-XIRDDKMYSA-N Ser-Leu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)CC(C)C)C(O)=O)=CNC2=C1 GVIGVIOEYBOTCB-XIRDDKMYSA-N 0.000 description 1
- SRKMDKACHDVPMD-SRVKXCTJSA-N Ser-Lys-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)N SRKMDKACHDVPMD-SRVKXCTJSA-N 0.000 description 1
- PPCZVWHJWJFTFN-ZLUOBGJFSA-N Ser-Ser-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O PPCZVWHJWJFTFN-ZLUOBGJFSA-N 0.000 description 1
- ODRUTDLAONAVDV-IHRRRGAJSA-N Ser-Val-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ODRUTDLAONAVDV-IHRRRGAJSA-N 0.000 description 1
- LOHBIDZYHQQTDM-IXOXFDKPSA-N Thr-Cys-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O LOHBIDZYHQQTDM-IXOXFDKPSA-N 0.000 description 1
- JWQNAFHCXKVZKZ-UVOCVTCTSA-N Thr-Lys-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JWQNAFHCXKVZKZ-UVOCVTCTSA-N 0.000 description 1
- KPMIQCXJDVKWKO-IFFSRLJSSA-N Thr-Val-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O KPMIQCXJDVKWKO-IFFSRLJSSA-N 0.000 description 1
- MJBBMTOGSOSAKJ-HJXMPXNTSA-N Trp-Ala-Ile Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O MJBBMTOGSOSAKJ-HJXMPXNTSA-N 0.000 description 1
- SNJAPSVIPKUMCK-NWLDYVSISA-N Trp-Glu-Thr Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SNJAPSVIPKUMCK-NWLDYVSISA-N 0.000 description 1
- ARKBYVBCEOWRNR-UBHSHLNASA-N Trp-Ser-Ser Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O ARKBYVBCEOWRNR-UBHSHLNASA-N 0.000 description 1
- IIJWXEUNETVJPV-IHRRRGAJSA-N Tyr-Arg-Ser Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(=O)O)N)O IIJWXEUNETVJPV-IHRRRGAJSA-N 0.000 description 1
- PMDWYLVWHRTJIW-STQMWFEESA-N Tyr-Gly-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 PMDWYLVWHRTJIW-STQMWFEESA-N 0.000 description 1
- VYQQQIRHIFALGE-UWJYBYFXSA-N Tyr-Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 VYQQQIRHIFALGE-UWJYBYFXSA-N 0.000 description 1
- SYFHQHYTNCQCCN-MELADBBJSA-N Tyr-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CC2=CC=C(C=C2)O)N)C(=O)O SYFHQHYTNCQCCN-MELADBBJSA-N 0.000 description 1
- LVFZXRQQQDTBQH-IRIUXVKKSA-N Tyr-Thr-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O LVFZXRQQQDTBQH-IRIUXVKKSA-N 0.000 description 1
- PQPWEALFTLKSEB-DZKIICNBSA-N Tyr-Val-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O PQPWEALFTLKSEB-DZKIICNBSA-N 0.000 description 1
- DDRBQONWVBDQOY-GUBZILKMSA-N Val-Ala-Arg Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O DDRBQONWVBDQOY-GUBZILKMSA-N 0.000 description 1
- KKHRWGYHBZORMQ-NHCYSSNCSA-N Val-Arg-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N KKHRWGYHBZORMQ-NHCYSSNCSA-N 0.000 description 1
- XKVXSCHXGJOQND-ZOBUZTSGSA-N Val-Asp-Trp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N XKVXSCHXGJOQND-ZOBUZTSGSA-N 0.000 description 1
- XXROXFHCMVXETG-UWVGGRQHSA-N Val-Gly-Val Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O XXROXFHCMVXETG-UWVGGRQHSA-N 0.000 description 1
- WBAJDGWKRIHOAC-GVXVVHGQSA-N Val-Lys-Gln Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(O)=O WBAJDGWKRIHOAC-GVXVVHGQSA-N 0.000 description 1
- CXWJFWAZIVWBOS-XQQFMLRXSA-N Val-Lys-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@@H]1C(=O)O)N CXWJFWAZIVWBOS-XQQFMLRXSA-N 0.000 description 1
- LLJLBRRXKZTTRD-GUBZILKMSA-N Val-Val-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)O)N LLJLBRRXKZTTRD-GUBZILKMSA-N 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 108010005233 alanylglutamic acid Proteins 0.000 description 1
- 108010052670 arginyl-glutamyl-glutamic acid Proteins 0.000 description 1
- 108010047857 aspartylglycine Proteins 0.000 description 1
- 108010068265 aspartyltyrosine Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 108010060199 cysteinylproline Proteins 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- FSXRLASFHBWESK-UHFFFAOYSA-N dipeptide phenylalanyl-tyrosine Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FSXRLASFHBWESK-UHFFFAOYSA-N 0.000 description 1
- 108010054812 diprotin A Proteins 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 108010049041 glutamylalanine Proteins 0.000 description 1
- 108010072405 glycyl-aspartyl-glycine Proteins 0.000 description 1
- 108010037850 glycylvaline Proteins 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 108010018006 histidylserine Proteins 0.000 description 1
- 238000009655 industrial fermentation Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 108010044374 isoleucyl-tyrosine Proteins 0.000 description 1
- 108010053037 kyotorphin Proteins 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 108010030617 leucyl-phenylalanyl-valine Proteins 0.000 description 1
- 108010025153 lysyl-alanyl-alanine Proteins 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000012269 metabolic engineering Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 108010084572 phenylalanyl-valine Proteins 0.000 description 1
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 1
- 108010025488 pinealon Proteins 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 108010038745 tryptophylglycine Proteins 0.000 description 1
- 108010044292 tryptophyltyrosine Proteins 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y599/00—Other isomerases (5.99)
- C12Y599/01—Other isomerases (5.99.1)
- C12Y599/01002—DNA topoisomerase (5.99.1.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/70—Vectors containing special elements for cloning, e.g. topoisomerase, adaptor sites
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明提供一种删除稳定载体上冗余片段的方法,采用该方法得到的稳定载体及其应用。所述方法包括以下步骤:1)将稳定载体导入罗氏真养菌中获得转化体,其中,所述稳定载体中的所述冗余片段的上游和下游各有1个重组酶特异性识别的核苷酸序列,并且所述稳定载体包含par区域中的启动子parP、质粒稳定化因子parA、parB、识别序列parS,复制蛋白repA,以及所述冗余片段;2)向所述转化体中导入表达所述重组酶的帮助质粒,经重组实现所述冗余片段的删除。本发明可以消除工业菌株中使用抗性基因所造成的抗性基因扩散到自然界的潜在隐患。
Description
技术领域
本发明属于基因工程领域,具体涉及一种删除稳定载体上冗余片段的稳定载体的方法及采用该方法得到的稳定载体。
背景技术
罗氏真养菌(Ralstonia eutropha,也被称作Cupriavidus necator)是研究PHA(聚羟基脂肪酸酯,一种完全可降解的生物基材料)合成的重要模式细菌,有潜力作为PHA工业生产的菌株。把一个目的基因通过基因工程手段送到生物细胞(受体细胞),需要运载工具携带外源基因进入受体细胞,这种运载工具就叫做载体(vector),而质粒是最常用的一种载体。在Ralstonia eutropha的菌种研发和工业生产中,经常使用质粒载体引入外来基因达到优化菌种的目的。
在构建质粒载体和选择宿主菌时要考虑到大规模生产中高产率问题及发酵和后续纯化中可能遇到的相关问题。质粒稳定性是质粒生产中经常遇到的问题之一,质粒的不稳定性指的是重组菌在培养过程中发生突变或丢失,结果使重组菌失去了原有的表型特征。质粒的分离不稳定是细胞分裂后子代细胞分离时引起的不稳定。由于质粒在子代细胞中的不均匀分配而使部分细胞不含有质粒,这也是质粒丢失的重要原因。在一般实验中,通常可以利用抗生素施加选择抗性以维持质粒稳定,但是考虑到工业发酵的体量,在实际生产中添加抗生素会大大增加成本。
par系统是用于稳定保持质粒的系统,par系统启动后,质粒复制后就被均匀分配到子细胞中,所以即使不通过抗生素抗性施加选择选择抗性也能获得稳定保有质粒的菌株(Salje J,Gayathri P,J.The ParMRC system:molecular mechanisms of plasmidsegregation by actin-like filaments[J].Nature Reviews Microbiology,2010,8(10):683-692.)。目前已经开发出一种利用par系统构建的,可以以Ralstonia eutropha为宿主、且不施加抗生素选择压力也能稳定保持的质粒载体。该载体使用耐金属贪铜菌CH34的巨大质粒pMOL28的par区域中的启动子parP、质粒稳定化因子parA28、parB28和识别序列parS。同时该载体上带有大肠杆菌复制子及卡那霉素抗性基因,以便于在大肠杆菌中进行载体改造相关的遗传操作(参见中国发明专利申请公开号CN101297036A)。
一般情况下,保持质粒的存在以及质粒的复制都需要依赖宿主细胞的代谢产生的能量,质粒拷贝数过高或质粒过大等会加重宿主细胞的代谢负担,严重的甚至影响宿主细胞生长(Karim A S,Curran K A,Alper H S.Characterization of plasmid burden andcopy number in Saccharomyces cerevisiae for optimization of metabolicengineering applications[J].Fems Yeast Research,2013;13(1):107-116.)。由于外源基因的大小通常不便于调节,在载体设计时就需要尽量精简,避免无效基因造成的复制负担。在质粒转化过程中,往往要依靠载体上的抗性基因对受体菌进行抗生素的压力筛选,以确保得到带有质粒的转化体。但对于稳定质粒载体而言,在质粒转入受体菌后,由于不再需要抗生素,载体上的抗性基因则失去利用价值,成为“无效”片段。
位点特异性重组系统由整合酶的识别位点/序列和识别DNA序列并介导DNA重组的整合酶组成。通过改变重组酶识别位点的位置和序列方向,位点特异性重组酶可以作为一种把特定序列插入到DNA链上或者从DNA链上删除或者翻转特定序列的工具酶。常用的位点特异性重组酶有TP901、PhiC31、P22和VCre等等。
现有技术中使用的载体含有在雷尔氏菌属、贪铜菌属和沃特氏菌属中发挥作用的DNA复制起始区域和稳定化重组载体的区域(par区域),该载体使用耐金属贪铜菌CH34的巨大质粒pMOL28的par区域中的启动子parP、质粒稳定化因子parA28、parB28和识别序列parS。所述载体没有抗生素选择压力也能够利用par系统在细菌中保持稳定。同时该载体上带有大肠杆菌复制子及卡那霉素抗性基因,以便于在大肠杆菌中进行载体改造相关的遗传操作。
现有技术的稳定载体,虽然无需加入抗生素,但是卡那霉素抗性基因依然存在且表达,对DNA复制和蛋白表达而言是一种多余的能量和原料消耗;而且,带有卡那霉素抗性基因的稳定载体应用于工业生产菌,存在卡那霉素抗性基因扩散到自然界的隐患;另外,稳定载体上留有可在大肠杆菌中复制的复制子,该复制子在载体转入Ralstonia细菌后不再发挥功能,是冗余片段,对DNA复制是多余的能量和原料消耗。
基于以上现状,需要提供一种方法,其能够删除上述重组载体中冗余的的大肠杆菌复制子及卡那霉素抗性基因从而提供一种适用于Ralstonia eutropha的稳定载体。
发明内容
本发明的一个目的是提供一种删除稳定载体上冗余片段的方法。
本发明的另一目的是提供一种通过上述方法获得的删除了冗余片段的稳定载体。
本发明的又一目的是提供一种上述稳定载体的用途。
本发明的再一目的是提供一种罗氏真养菌重组菌,其包含通过上述方法删除了冗余片段的稳定载体。
本发明的又一目的是提供所述罗氏真养菌重组菌用于PHA生产的用途。
一方面,本发明提供一种删除稳定载体上冗余片段的方法,所述方法包括以下步骤:
1)将稳定载体导入罗氏真养菌中获得转化体,其中,所述稳定载体中的冗余片段的上游和下游各有1个重组酶特异性识别的核苷酸序列,并且所述稳定载体包含par区域中的启动子parP、质粒稳定化因子parA、parB、识别序列parS,复制蛋白repA,以及所述冗余片段;
2)向所述转化体中导入表达所述重组酶的帮助质粒,经重组实现所述冗余片段的删除。
本发明方法中,优选地,所述重组酶可以选自VCre重组酶、Bxb1重组酶、phiC31重组酶、TP901重组酶、HK022重组酶、Phi80重组酶、P21重组酶、Int3重组酶、Int4重组酶、Int5重组酶、Int9重组酶、Int11重组酶、Int12重组酶、Int13重组酶、P22重组酶、lamda重组酶、Cre重组酶、Dre重组酶、Vika重组酶、Flp重组酶、FimE重组酶、HbiF重组酶、A118重组酶中。
在具体实施方式中,所述重组酶为VCre重组酶,所述重组酶特异性识别的核苷酸序列为VloxP序列(SEQ ID No.:20)。
在具体实施方式中,所述VCre重组酶的氨基酸序列如SEQ ID No.:22所示。
在具体实施方式中,所述VCre重组酶的核苷酸序列如SEQ ID No.:21所示。
在具体实施方式中,所述par区域的核苷酸序列包含如SEQ ID No.:25所示的序列。
在具体实施方式中,所述复制蛋白repA为复制蛋白repA28,其包含如SEQ ID No.:26所示的序列。
本发明方法中,优选地,可选的par序列还可包括RP4、RK2的载体稳定化区域。
本发明中,所述罗氏真养菌的实例没有特别的限制,其可以是本领域中的用于PHA生产的任何罗氏真养菌。在具体实施方式中,所述罗氏真养菌是Ralstonia eutropha H16。
本发明中的所述的“冗余片段”是指稳定载体在导入罗氏真氧菌之后其序列中不再发挥功能的和/或没有应用意义的基因片段和/或核苷酸序列。
在具体实施方式中,所述冗余片段包括抗性基因。优选地,所述抗性基因是抗生素抗性基因。
在具体实施方式中,所述抗性基因是卡那霉素抗性基因。
在具体实施方式中,所述冗余片段还包括大肠杆菌复制子。
在具体实施方式中,所述Ptet诱导型也可以用表达VCre的其他启动子代替,包括但不限于诱导型启动子Ptac、pBAD、pRha、pTrp、T7启动子、热诱导启动子等,以及组成型启动子J23119和其他J231xx系列、原核细胞中Sigma70因子介导转录的组成型启动子等。
另一方面,本发明提供一种通过上述方法得到的适用于罗氏真养菌的稳定载体。
再一方面,本发明提供了上述稳定载体在基因工程中的应用。
再一方面,本发明提供了上述稳定载体用于罗氏真养菌中的应用。
再一方面,本发明提供了一种罗氏真养菌重组菌,其包含通过上述方法删除了冗余片段的稳定载体。
再一方面,本发明提供了上述罗氏真养菌重组菌用于聚羟基脂肪酸酯(PHA)生产的用途。
有益效果
本发明的有益技术效果在于,一方面,避免了稳定载体在罗氏真养菌中使用时冗余的大肠杆菌复制子和抗性基因的DNA复制和蛋白表达,从而节约能量并且减少了原料消耗;另一方面,避免了工业菌株中使用抗性基因所造成的抗性基因扩散到自然界的潜在隐患。
附图说明
图1为根据本发明的稳定载体通过含有重组酶VCre基因的载体删除大肠杆菌复制子和抗生素抗性基因的示意图。
图2显示实施例2中Ralstonia eutropha H16(pSP-kana-GFP)在添加或未添加卡那霉素两种情形下的质粒保留率。
图3显示比较例2中的Ralstonia eutropha H16(pBBR1-GFP)在添加或未添加卡那霉素两种情形下的质粒保留率。
图4显示使用帮助质粒pVCre删除大肠杆菌p15A复制子和卡那霉素抗性基因前(第1-3泳道)/后(第5-7泳道)的PCR结果。
图5显示未删除p15A复制子和卡那霉素抗性基因的Ralstonia eutropha H16(pSP-kana-GFP)和删除了p15A复制子和卡那霉素抗性基因的Ralstonia eutropha H16(pSP-GFP)的质粒保留率。
具体实施方式
在下文中,将通过实施例详细描述本发明。然而,在此提供的实施例仅用于说明目的,并不用于限制本发明。
下述实施例所使用的实验方法如无特殊说明,均为常规方法。
下述实施例所用的材料、试剂等,如无特殊说明,均可从商业途径得到。
所用酶试剂采购自ThermoFisher公司和New England Biolabs(NEB)公司,提取质粒所用的试剂盒购自天根生化科技(北京)有限公司,回收DNA片段的试剂盒购自美国omega公司,相应的操作步骤严格按照产品说明书进行,所有培养基如无特殊说明均用去离子水配制。
培养基配方:
LB培养基:5g/L酵母提取物(购自英国OXID公司,产品目录号LP0021),10g/L蛋白胨(购自英国OXID公司,产品目录号LP0042),10g/L NaCl,其余为水。调pH值至7.0-7.2,高压蒸汽灭菌。
实施例1:用质粒载体pSP制备整合绿色荧光蛋白(GFP)的质粒pSP-kana-GFP
用引物1(SEQ ID No.:1)和引物2(SEQ ID No.:2)以合成片段01(SEQ ID No.:15)为模板扩增得到含有p15A复制子和卡那霉素抗性基因的片段,用引物3(SEQ ID No.:3)和引物4(SEQ ID No.:4)以合成片段02(SEQ ID No.:16)为模板扩增得到含有par区域的片段,用引物7(SEQ ID No.:5)和引物8(SEQ ID No.:6)以合成片段03(SEQ ID No.:17)为模板扩增得到含有复制起始蛋白Rep及限制性内切酶BsaI位点的片段,将获得的三个片段按照商业试剂盒(Master Mix,购买自New England Biolabs(NEB)公司)的说明通过Gibson Assembly方法连接,得到带有卡那霉素抗性的pSP载体,p15A复制子的上游和卡那霉素抗性基因的下游各有1个VCre重组酶(氨基酸序列SEQ ID No.:22,基因序列SEQ ID No.:21)特异性识别的VloxP序列(SEQ ID No.:20)。使用的引物如下表1:
表1
使用BsaI处理合成片段04(SEQ ID No.:18),其中包括GFP绿色荧光蛋白基因,酶切片段通过Golden Gate(Werner S,Engler C,Weber E,et al.Fast track assembly ofmultigene constructs using Golden Gate cloning and the MoClo system[J].Bioengineered bugs,2012,3(1):38-43.)导入pSP载体的限制性内切酶BsaI位点,得到使用pSP载体构建的pSP-kana-GFP质粒。
将质粒pSP-kana-GFP转入大肠杆菌S17-1(ATCC编号:47055,可购自美国菌种保藏中心American Type Culture Collection)中,再通过接合转化方法转入Ralstoniaeutropha H16(中国普通微生物菌种保藏管理中心,CGMCC 1.7092)中,用同时含有250μg/ml卡那霉素与50μg/ml安普霉素的LB平板筛选带有绿色荧光的阳性克隆,即得到用pSP载体构建的转化体Ralstonia eutropha H16(pSP-kana-GFP)。
比较例1:用载体pBBR1MCS2制备整合绿色荧光蛋白(GFP)的质粒pBBR1-GFP
用引物9(SEQ ID No.:7)和引物10(SEQ ID No.:8)以质粒pBBR1MCS-2(KovachME,Elzer PH,Hill DS,Robertson GT,Farris MA,Roop RM,Peterson KM.,1995.Four newderivatives of the broad-host-range cloning vector pBBR1MCS,carryingdifferent antibiotic-resistance cassettes.Gene.166,175-176)为模板PCR扩增得到载体片段,片段上带有复制子及卡那霉素抗性基因;用引物11(SEQ ID No.:9)和引物12(SEQ ID No.:10)以合成片段04(SEQ ID No.:18)为模板扩增得到含有GFP基因的DNA片段;通过Gibson Assembly方法将两片段相连接,得到用质粒载体pBBR1MCS2制备整合绿色荧光蛋白(GFP)的质粒pBBR1-GFP。使用的引物如下表2。
表2
使用与实施例1同样的方法将pBBR1-GFP质粒转入Ralstonia eutropha H16,即得到转入pBBR1-GFP质粒的Ralstonia eutropha H16(pBBR1-GFP)。
实施例2:Ralstonia eutropha H16(pSP-kana-GFP)的质粒保留率(plasmidretention rate)
使用流式细胞仪鉴定了Ralstonia eutropha H16(pSP-kana-GFP)的质粒保留率。测定如下进行:分别用含有250μg/ml卡那霉素和未添加抗生素的LB液体培养基对转化体进行摇床培养(30℃,220rpm/min),每24小时传代一次,测定连续传代2、4、6、8天后的转化体质粒保留率。
首先将转接菌液用10×PBS(购自北京Solarbio公司,产品货号P1022)溶液调菌液OD值为0.012,吸取200μl稀释后的菌液加入96孔板(购自美国Corning公司,产品目录号351172),使用流式细胞仪(贝克曼CytoFLEX)对每个样品中带绿色荧光的细胞数进行统计,只有保留了pSP-kana-GFP的转化体才能发出绿色荧光,其占所有细胞总数的百分比即为质粒保留率。具体实验操作按照仪器说明书执行。结果如图2。
从图2中可以看出,Ralstonia eutropha H16(pSP-kana-GFP)在不添加卡那霉素抗性条件下连续转接后,质粒没有明显丢失现象,质粒保留率在转接8天后依然保持在90%以上,与添加卡那霉素条件下进行转接没有显著差异。根据以上结果可以认为pSP载体在不施加抗生素条件下能够稳定保持。
比较例2:Ralstonia eutropha H16(pBBR1-GFP)的质粒保留率
用Ralstonia eutropha H16(pBBR1-GFP)代替实施例1中的Ralstonia eutrophaH16(pSP-kana-GFP),以实施例2中相同的方法测定质粒保留率。结果如图3。
从图3可以看出,Ralstonia eutropha H16(pBBR1-GFP)在不添加卡那霉素抗性条件下连续转接后,质粒明显丢失,转接8天后仅有不到10%的转化体保留了pBBR1-GFP质粒,与添加卡那霉素条件下进行转接有显著差异。根据以上结果可以认为pBBR1MCS2载体不施加抗生素选择压力不能稳定保持。
实施例3:用帮助质粒删除pSP-kana-GFP质粒上的卡那霉素抗性基因
用引物13(SEQ ID No.:11)和引物14(SEQ ID No.:12)以质粒pBBR1MCS2为模板PCR扩增得到载体片段,片段上带有复制子及卡那霉素抗性基因;用引物15(SEQ ID No.:13)和引物16(SEQ ID No.:14)以合成片段05(SEQ ID No.:19)为模板扩增得到含有Ptet诱导型启动子、VCre基因(SEQ ID No.:21)及壮观霉素抗性基因的DNA片段;通过GibsonAssembly方法将两片段相连接,得到帮助质粒pVCre。使用的引物如下表3。
表3
将帮助质粒pVCre转入大肠杆菌S17-1中,通过接合转化方法转入实施例1中得到的转化体,用同时含有500μg/ml壮观霉素与50μg/ml安普霉素的LB平板,随机挑取3个带有绿色荧光的克隆,用引物17(SEQ ID No.:23)和引物18(SEQ ID No.:24)进行PCR验证,得到预期的1104bp的条带,使用同样引物对转化体Ralstonia eutropha H16(pSP-kana-GFP)进行扩增作为对照,得到预期的3074bp条带(图4),证明导入的含有VCre重组酶的基因的帮助质粒pVCre删除了片段长度为1970bp的p15A复制子和卡那霉素抗性基因。最后,将阳性克隆在无抗性平板上培养丢失pVCre质粒,即得到无p15A复制子和卡那霉素抗性基因的pSP载体转化体Ralstonia eutropha H16(pSP-GFP)。
实施例4:Ralstonia eutropha H16(pSP-GFP)的质粒保留率
以实施例2中相同的方法,用Ralstonia eutropha H16(pSP-GFP)在无抗条件下测定质粒保留率,同时用Ralstonia eutropha H16(pSP-kana-GFP)作为对照。结果如图5所示。
从图5中可以看出,Ralstonia eutropha H16(pSP-GFP)在不添加卡那霉素抗性条件下连续转接后,质粒没有明显丢失现象,与Ralstonia eutropha H16(pSP-kana-GFP)没有显著差异。根据以上结果可以认为pSP-kana-GFP在删除卡那霉素抗性基因及p15A复制子后依然能够稳定保持。
总结上述内容,本申请构建的删除了p15A复制子和卡那霉素抗性基因的载体相对于未删除上述基因的载体的稳定保持率没有显著差异,另外,本申请构建的稳定载体消除了卡那霉素抗性基因扩散到自然界的隐患。
序列表
<110> 深圳蓝晶生物科技有限公司
<120> 删除稳定载体上冗余片段的方法,采用该方法得到的稳定载体及其应用
<130> DI20-1223-XC03
<160> 26
<170> PatentIn version 3.5
<210> 1
<211> 47
<212> DNA
<213> 人工序列
<220>
<223> 引物 1
<400> 1
cgtctcattt tcgccagata tcggtagcgg agtgtatact ggcttac 47
<210> 2
<211> 23
<212> DNA
<213> 人工序列
<220>
<223> 引物 2
<400> 2
tcagaagaac tcgtcaagaa ggc 23
<210> 3
<211> 23
<212> DNA
<213> 人工序列
<220>
<223> 引物 3
<400> 3
gccttcttga cgagttcttc tga 23
<210> 4
<211> 21
<212> DNA
<213> 人工序列
<220>
<223> 引物 4
<400> 4
gcataaggtt cgcgtagaac g 21
<210> 5
<211> 21
<212> DNA
<213> 人工序列
<220>
<223> 引物 7
<400> 5
cgttctacgc gaaccttatg c 21
<210> 6
<211> 23
<212> DNA
<213> 人工序列
<220>
<223> 引物 8
<400> 6
cgatatctgg cgaaaatgag acg 23
<210> 7
<211> 49
<212> DNA
<213> 人工序列
<220>
<223> 引物 9
<400> 7
cgatttaaat tggcgaaaat gagacgtatc gaattcctgc agcccgggg 49
<210> 8
<211> 40
<212> DNA
<213> 人工序列
<220>
<223> 引物 10
<400> 8
aagcacatcc ggtgacagct atcaagctta tcgataccgt 40
<210> 9
<211> 20
<212> DNA
<213> 人工序列
<220>
<223> 引物 11
<400> 9
agctgtcacc ggatgtgctt 20
<210> 10
<211> 27
<212> DNA
<213> 人工序列
<220>
<223> 引物 12
<400> 10
acgtctcatt ttcgccaatt taaatcg 27
<210> 11
<211> 49
<212> DNA
<213> 人工序列
<220>
<223> 引物 13
<400> 11
cgatttaaat tggcgaaaat gagacgtatc gaattcctgc agcccgggg 49
<210> 12
<211> 45
<212> DNA
<213> 人工序列
<220>
<223> 引物 14
<400> 12
cgatatctgg cgaaaatgag acgatatcaa gcttatcgat accgt 45
<210> 13
<211> 23
<212> DNA
<213> 人工序列
<220>
<223> 引物 15
<400> 13
cgtctcattt tcgccagata tcg 23
<210> 14
<211> 27
<212> DNA
<213> 人工序列
<220>
<223> 引物 16
<400> 14
acgtctcatt ttcgccaatt taaatcg 27
<210> 15
<211> 1912
<212> DNA
<213> 人工序列
<220>
<223> 合成片段 01
<400> 15
gtagcggagt gtatactggc ttactatgtt ggcactgatg agggtgtcag tgaagtgctt 60
catgtggcag gagaaaaaag gctgcaccgg tgcgtcagca gaatatgtga tacaggatat 120
attccgcttc ctcgctcact gactcgctac gctcggtcgt tcgactgcgg cgagcggaaa 180
tggcttacga acggggcgga gatttcctgg aagatgccag gaagatactt aacagggaag 240
tgagagggcc gcggcaaagc cgtttttcca taggctccgc ccccctgaca agcatcacga 300
aatctgacgc tcaaatcagt ggtggcgaaa cccgacagga ctataaagat accaggcgtt 360
tcccctggcg gctccctcgt gcgctctcct gttcctgcct ttcggtttac cggtgtcatt 420
ccgctgttat ggccgcgttt gtctcattcc acgcctgaca ctcagttccg ggtaggcagt 480
tcgctccaag ctggactgta tgcacgaacc ccccgttcag tccgaccgct gcgccttatc 540
cggtaactat cgtcttgagt ccaacccgga aagacatgca aaagcaccac tggcagcagc 600
cactggtaat tgatttagag gagttagtct tgaagtcatg cgccggttaa ggctaaactg 660
aaaggacaag ttttggtgac tgcgctcctc caagccagtt acctcggttc aaagagttgg 720
tagctcagag aaccttcgaa aaaccgccct gcaaggcggt tttttcgttt tcagagcaag 780
agattacgcg cagaccaaaa cgatctcaag aagatcatct tattaaaggg tccccaataa 840
ttacgattta aattggatga atgtcagcta ctgggctatc tggacaaggg aaaacgcaag 900
cgcaaagaga aagcaggtag cttgcagtgg gcttacatgg cgatagctag actgggcggt 960
tttatggaca gcaagcgaac cggaattgcc agctggggcg ccctctggta aggttgggaa 1020
gccctgcaaa gtaaactgga tggctttctt gccgccaagg atctgatggc gcaggggatc 1080
aagatctgat caagagacag gatgaggatc gtttcgcatg attgaacaag atggattgca 1140
cgcaggttct ccggccgctt gggtggagag gctattcggc tatgactggg cacaacagac 1200
aatcggctgc tctgatgccg ccgtgttccg gctgtcagcg caggggcgcc cggttctttt 1260
tgtcaagacc gacctgtccg gtgccctgaa tgaactgcag gacgaggcag cgcggctatc 1320
gtggctggcc acgacgggcg ttccttgcgc agctgtgctc gacgttgtca ctgaagcggg 1380
aagggactgg ctgctattgg gcgaagtgcc ggggcaggat ctcctgtcat ctcaccttgc 1440
tcctgccgag aaagtatcca tcatggctga tgcaatgcgg cggctgcata cgcttgatcc 1500
ggctacctgc ccattcgacc accaagcgaa acatcgcatc gagcgagcac gtactcggat 1560
ggaagccggt cttgtcgatc aggatgatct ggacgaagag catcaggggc tcgcgccagc 1620
cgaactgttc gccaggctca aggcgcgcat gcccgacggc gaggatctcg tcgtgaccca 1680
tggcgatgcc tgcttgccga atatcatggt ggaaaatggc cgcttttctg gattcatcga 1740
ctgtggccgg ctgggtgtgg cggaccgcta tcaggacata gcgttggcta cccgtgatat 1800
tgctgaagag cttggcggcg aatgggctga ccgcttcctc gtgctttacg gtatcgccgc 1860
tcccgattcg cagcgcatcg ccttctatcg ccttcttgac gagttcttct ga 1912
<210> 16
<211> 2503
<212> DNA
<213> 人工序列
<220>
<223> 合成片段 02
<400> 16
gccttcttga cgagttcttc tgatcaattt ccgagaatga cagttctcag aaattgattt 60
gacttttgtc cttttccgct gcataaccct gcttcggggt cattatagcg attttttcgg 120
tatatccatc ctttttcgca cgatatacag gattttgcca aagggttcgt gtagactttc 180
cttggtgtat ccaacggcgt cagccgggca ggataggtga agtaggccca cccgcgagcg 240
ggtgttcctt cttcactgtc ccttattcgc acctggcggt gctcaacggg aatcctgctc 300
tgcgaggctg gccgtaggcc ggccgcgatg caggtggctg ctgaaccccc agccggaact 360
gaccccacaa ggccctgtac acgcctcaaa aggacgggag tgggacagcg tagccatagt 420
ccgagccgaa gagacaatcg ttcccgacag cgaaagccca gaaagcgaag aaaggcgcct 480
cttctacgtc gccgtcacgc gcgccaggga ttgcctgttt atctcaacgg cgaagaagaa 540
cccgacctcg cgcttcgtcc ttgaggctgg cctaagcctt acttcctgag gcgcgcattc 600
tttgtgcgtt atatggcact ttcgtagaat tcctcgcctt ttactttaac aacgacccgt 660
aagtaccggg ggaacagctc gatctctcgg gtacaacagg cacaaagtta acttgcgtat 720
acgtctaagg gccgctaacc ttcacggcaa cgcaaccgcg gacgtcattt ttgccgaaaa 780
cggttgcacg atccaccggc ggttccggtg aacagcttaa aggtttttga accgaatgga 840
tatcaagcta gcccacccca gcaagacgac gcctgaggat ttgaagcagt tggcaaatct 900
ctccgcggtg atgctgcaga aaattcggga tgagatgctg gagccatttc ctcggaagga 960
agccccgctg atcccgtctg gccgcctaca agaattgtgt ggcatcgaca aaacgcggat 1020
gaaccggtcc ctcaaaaagg gggatctccc tcagggccag caatcgcgac ccggtgcagt 1080
gcgctatttc agcctcagcg aggcaatgca atggatccga gcggaactta agcctgtccc 1140
gcgaagggga ccaggtaaag tcattgcagt tgcgaacttc aagggcggtg tcacgaagac 1200
cactatgtcc accctcctct gccagggctt gagtctgcgg cgaggtcgga aggtgtgcca 1260
cgttgatctg gatccgcagg gaagcgcaac cacgctgtat ggcatcaatc cacatgccga 1320
ggtgtcgtcc gaaaacacca ttatgccgct catcgaggcg tatttggcgg gcgagtcctt 1380
cgatatgcga gggcttcctc aggagactta ctggcctaac ctggatttga ttccttcgtc 1440
tactgagctt ttcaacgcgg agtttatgct tccggctcgg gcgacggcag aggaaggcca 1500
tattccgttc gagcgcgtgt taagtaacgg cctcgattcg ttgaaagacg aatatgacta 1560
catcatcctc gacacggctc ctaccctcag ctacctgacc atcaacgcga ttttcgctgc 1620
cgatggcgtc atcgtaccgg tggtcccgga caccttggct ttcgcgtcta tggtccagtt 1680
ctggcaactc ttctcggacc tagtaacagg catggaagag cagagcgagg gatctaaaaa 1740
ggagttcgac tttctcgatg ttctcatgac acgcatggag aaaaagaacg ctcctcgcct 1800
ggtggcagac tggattcgcg gcgtctatgg gtcgcgcgtg ctgccgattg agatccctga 1860
gacggacctc gcccgtaaca gcagcattca atttcgcacg gtctatgacc tctcctctag 1920
cgaggcgaac accgagacga tgcgacgcat tcgccaaccc tgcgatgagt ttgtcgacta 1980
tgtggacgac aaggtcagcg cgctttggca aggaattgaa gaatgagttt gagagaaaag 2040
cttgccgcaa aggctgggaa catcaaggtc acggcggaag acttggagaa agccgctgcg 2100
cgcggtccgc aagcgccgcg aactgcgccc ggtcagttaa tgcatatgca agggaaggtt 2160
gagcgacagg ctaacgagat cgcgcaacta agagcagaac ttgagtcggc ccgcgtcagc 2220
ggcggcgcag tggatgtgcc tatcgaccaa ctgcatgagg tcccaggccg cagacgcttc 2280
atgcctcccg agaagtatgt cgaattgagg gaaaacctca ggcacaacaa gctcgttcat 2340
cctgtgattg tatgccctcg gcctgcggga ggcttcgaga ttgtctccgg gcatcaccgg 2400
acagacgcgt accgcgagct tgggcgcgat cacatacgct gcgtgctcgg cgaacttagt 2460
tcagacgagg ctgacacggg cgcgttctac gcgaacctta tgc 2503
<210> 17
<211> 2381
<212> DNA
<213> 人工序列
<220>
<223> 合成片段 03
<400> 17
cgttctacgc gaaccttatg cagtcagatt taacggattt cgagaagttt cggaagttcg 60
acgaactgct gcttcgcagc ccagacaaga ctcaagccgc aatagctgaa caggctggtg 120
tacctgtctc gactctctca gagattttgt cgttccggaa cttgcctccc gaggtcctaa 180
gccttctcga tagccgccca gacctgctcg ggtcgaatgc tggcgccgag ttggcaaggg 240
cgaccaaaga cggtcgcggg gatcgggtcg tcgaagcggt taagttgttg gccgagaaga 300
agatcgatca acagcaggcc gtacggatga ctaaggccga gcaggttaag accaggcctg 360
ccgcatctac cggcttcaaa atcaaggcgg gaaaggcgac ttggtgcgat gttcgtatcg 420
caaagaaagt catgcgcatt gagttccgca gcgaggaaga agcggaagcg gcccaatcgg 480
ccattcgcga acatctggaa gggttagcta aagctgcgtc ggaagacgca aaaagctaag 540
tgcttgtttt ttaaggactt cgtactacga atcgaggttt taagccatgt ctagactgta 600
atcctacaaa aacaaaagcc cacggcggca accgtgggct tttgagaact tcaagctgac 660
cagtttcccg gccgctacac accgaagcca ctcgacatgg attcgttagt cggagtgtag 720
cggaacgcga acctgagtca agcgacttca accatttttt acgaatggga aggtcatatg 780
actttcgcgc aacgctccgt tgctggcgag gatgttgctc gcccacaaaa acaccttaac 840
cagacagacg ctctgattgc tccggcgccc aagcgcctca aacgcaagac tatcgaagca 900
gtcgagcgcg caactcgaat cgtcgggatc gggcgtagcg cccgatcagc tcttgccgcc 960
ctcgcccgca cggcgaataa cgatgacccc accggtaaga tctttaagca ccgggaaacg 1020
ctttgtgccg aaaccggaat gtcgccggct acttggtacc gtgctcaacg agaactgctc 1080
gacttgggcc taattaccgt cgacgttcaa gttcggaagc gatttggccg attcgcagga 1140
gcctacattt acctgacgga aaaagcgacg gagatgctcg gcttaagctc gcgaaaagaa 1200
gaagaaacca cgggtacggg cgaggacgac acagcgcagc tcggcgagcc ggccgttcca 1260
ccaccctctt ctatggcgca accgtctctc aaaacgagag tcctgtttac agaagatcgt 1320
gtcccatact cctttcaaaa aagacagcag gatcggctcc cccaggacct gacacgtctg 1380
cgcggcctgg gtcttgatgt aaatttaatt ttttggttga tgcgaaaggc taaagagcaa 1440
ggccactttc tctcagatgt cgtaagcgcg acatgggaga gtcttgcgaa agcacgcgtg 1500
ccaaaagcgt atctgcttgc cctactcacc gcccgcaccg atttcagtgc tgtctgcaaa 1560
gcaaaggcac tcaaagaaga caaagcccga atccaagtgc aggaccgcga tttcgtgcgt 1620
tcgatactcg caggggcagc gcggcagtgt ttcgtggacg aaaaaggcaa ccatttcgaa 1680
gtcgaaagcg acggaagctc agtgcttgtc accgaggtcc aaagtgcggt cacttcccgc 1740
ttggtaggaa cttccctcgc cgaatttgca aggcgactac acgctggtgc gtaccagaaa 1800
gctgaggtct acgctgctcc ccagagagca agcggccggc tcgagaaacg gggaaaggag 1860
gcggcttcga cgttatcggc gttgcgagcg atgctgcgcg accgcaggtc agccaacgcg 1920
gcaaacacga cgaacaatgc tcatgccatg gcctagggtg tgttttgcgc tgaaagtcta 1980
gggcggcgga tttgtcctac tcaggagagc gttcaccgac aaacaacaga taaaacgaaa 2040
ggcccagtct ttcgactgag cctttcgttt tatttgatgc ctttaattaa agcggataac 2100
aatttcacac aggagagtga agagcttttg ctcttcatcc aagcgagacc aaaaggtctc 2160
gccgcgaccc attaccgcct ttgagtgagc gtcgtgactg ggaaaaccct ggcgactagt 2220
cttggactcc tgttgataga tccagtaatg acctcagaac tccatctgga tttgttcaga 2280
acgctcggtt gccgccgggc gttttttatt ggtgagaatc cagtcaattt ccgagaatga 2340
cagttctcag aaattgaacg tctcattttc gccagatatc g 2381
<210> 18
<211> 1549
<212> DNA
<213> 人工序列
<220>
<223> 合成片段 04
<400> 18
agctgtcacc ggatgtgctt tccggtctga tgagtccgtg aggacgaaac agcctctaca 60
aataattttg tttaagagcg gcgagacctt tcacacagga atgcctccac accgctcgtc 120
acatcctgtt gcgttcactg gaatcccagt atagactttg acctgcgagc aagctgtcac 180
cggatgtgct ttccggtctg atgagtccgt gaggacgaaa cagcctctac aaataatttt 240
gtttaagagt tactagagaa agaggagaaa tactagatgc gtaaaggcga agagctgttc 300
actggtgtcg tccctattct ggtggaactg gatggtgatg tcaacggtca taagttttcc 360
gtgcgtggcg agggtgaagg tgacgcaact aatggtaaac tgacgctgaa gttcatctgt 420
actactggta aactgccggt accttggccg actctggtaa cgacgctgac ttatggtgtt 480
cagtgctttg ctcgttatcc ggaccatatg aagcagcatg acttcttcaa gtccgccatg 540
ccggaaggct atgtgcagga acgcacgatt tcctttaagg atgacggcac gtacaaaacg 600
cgtgcggaag tgaaatttga aggcgatacc ctggtaaacc gcattgagct gaaaggcatt 660
gactttaaag aagacggcaa tatcctgggc cataagctgg aatacaattt taacagccac 720
aatgtttaca tcaccgccga taaacaaaaa aatggcatta aagcgaattt taaaattcgc 780
cacaacgtgg aggatggcag cgtgcagctg gctgatcact accagcaaaa cactccaatc 840
ggtgatggtc ctgttctgct gccagacaat cactatctga gcacgcaaag cgttctgtct 900
aaagatccga acgagaaacg cgatcatatg gttctgctgg agttcgtaac cgcagcgggc 960
atcacgcatg gtatggatga actgtacaaa taatcgtcac tccaccggtg cttaataacc 1020
aggcatcaaa taaaacgaaa ggctcagtcg aaagactggg cctttcgttt tatctgttgt 1080
ttgtcggtga acgctctcta ctagagtcac actggctcac cttcgggtgg gcctttctgc 1140
gtttatatac tagagctgct aacaaagccc gaaaggaagc tgagttggct gctgccaccg 1200
ctgagcaata actagcataa ccccttgggg cctctaaacg ggtcttgagg ggttttttgc 1260
tgaaaggagg aactatatcc ggattactag aggtcatgct tgccatctgt tttcttgcaa 1320
gatgctcact caaaggcggt aatgggtcga tgaagagcaa aagctcttca ctcgtcgtga 1380
ctgggaaaac cctggcggtc tcgcttggac tcctgttgat agatccagta atgacctcag 1440
aactccatct ggatttgttc agaacgctcg gttgccgccg ggcgtttttt attggtgaga 1500
atccaggggt ccccaataat tacgatttaa attggcgaaa atgagacgt 1549
<210> 19
<211> 2185
<212> DNA
<213> 人工序列
<220>
<223> 合成片段 05
<400> 19
cgtctcattt tcgccagata tcgacgtctt aagacccact ttcacattta agttgttttt 60
ctaatccgca tatgatcaat tcaaggccga ataagaaggc tggctctgca ccttggtgat 120
caaataattc gatagcttgt cgtaataatg gcggcatact atcagtagta ggtgtttccc 180
tttcttcttt agcgacttga tgctcttgat cttccaatac gcaacctaaa gtaaaatgcc 240
ccacagcgct gagtgcatat aatgcattct ctagtgaaaa accttgttgg cataaaaagg 300
ctaattgatt ttcgagagtt tcatactgtt tttctgtagg ccgtgtacct aaatgtactt 360
ttgctccatc gcgatgactt agtaaagcac atctaaaact tttagcgtta ttacgtaaaa 420
aatcttgcca gctttcccct tctaaagggc aaaagtgagt atggtgccta tctaacatct 480
caatggctaa ggcgtcgagc aaagcccgct tattttttac atgccaatac aatgtaggct 540
gctctacacc tagcttctgg gcgagtttac gggttgttaa accttcgatt ccgacctcat 600
taagcagctc taatgcgctg ttaatcactt tacttttatc taatctagac atcattaatt 660
cctaattttt gttgacactc tatcgttgat agagttattt taccactccc tatcagtgat 720
agagaaaaga attcaagctg tcaccggatg tgctttccgg tctgatgagt ccgtgaggac 780
gaaacagcct ctacaaataa ttttgtttaa tactagagaa agaggagaaa tactagatga 840
tcgagaacca gctgagcctg ctgggtgatt tcagcggcgt gcgtccggac gatgttaaga 900
ccgcgatcca ggcggcgcaa aagaaaggta ttaacgttgc ggagaacgaa caattcaaag 960
cggcgtttga gcacctgctg aacgagttca agaaacgtga ggaacgttac agcccgaaca 1020
ccctgcgtcg tctggaaagc gcgtggacct gctttgtgga ttggtgcctg gcgaaccatc 1080
gtcacagcct gccggcgacc ccggacaccg ttgaggcgtt ctttatcgaa cgtgcggagg 1140
aactgcaccg taacaccctg agcgtgtacc gttgggcgat tagccgtgtt catcgtgttg 1200
cgggttgccc ggacccgtgc ctggatatct atgtggagga tcgtctgaag gcgattgcgc 1260
gtaagaaagt gcgtgagggc gaagcggtta aacaggcgag cccgtttaac gaacaacacc 1320
tgctgaagct gaccagcctg tggtaccgta gcgacaaact gctgctgcgt cgtaacctgg 1380
cgctgctggc ggtggcgtat gagagcatgc tgcgtgcgag cgaactggcg aacatccgtg 1440
ttagcgacat ggagctggcg ggtgatggca ccgcgattct gaccatcccg attaccaaga 1500
ccaaccacag cggcgagccg gacacctgca ttctgagcca ggatgtggtt agcctgctga 1560
tggactacac cgaagcgggc aagctggaca tgagcagcga tggtttcctg tttgtgggcg 1620
ttagcaaaca caacacctgc atcaagccga agaaagataa acagaccggt gaagttctgc 1680
acaagccgat taccaccaaa accgtggagg gcgttttcta tagcgcgtgg gaaaccctgg 1740
atctgggtcg tcaaggcgtg aagccgttta ccgcgcacag cgcgcgtgtt ggtgcggcgc 1800
aggacctgct gaagaaaggc tacaacaccc tgcaaatcca gcaaagcggt cgttggagca 1860
gcggcgcgat ggttgcgcgt tatggtcgtg cgatcctggc gcgtgacggc gcgatggcgc 1920
acagccgtgt gaaaacccgt agcgcgccga tgcaatgggg caaggacgag aaagattaat 1980
gataagtagc ggagtgtata ctggcttacg tcgtgactgg gaaaaccctg gcgactagtc 2040
ttggactcct gttgatagat ccagtaatga cctcagaact ccatctggat ttgttcagaa 2100
cgctcggttg ccgccgggcg ttttttattg gtgagaatcc aggggtcccc aataattacg 2160
atttaaattg gcgaaaatga gacgt 2185
<210> 20
<211> 34
<212> DNA
<213> 人工序列
<220>
<223> VloxP序列
<400> 20
tcaatttccg agaatgacag ttctcagaaa ttga 34
<210> 21
<211> 1143
<212> DNA
<213> 人工序列
<220>
<223> VCre重组酶的基因序列
<400> 21
atgatcgaga accagctgag cctgctgggt gatttcagcg gcgtgcgtcc ggacgatgtt 60
aagaccgcga tccaggcggc gcaaaagaaa ggtattaacg ttgcggagaa cgaacaattc 120
aaagcggcgt ttgagcacct gctgaacgag ttcaagaaac gtgaggaacg ttacagcccg 180
aacaccctgc gtcgtctgga aagcgcgtgg acctgctttg tggattggtg cctggcgaac 240
catcgtcaca gcctgccggc gaccccggac accgttgagg cgttctttat cgaacgtgcg 300
gaggaactgc accgtaacac cctgagcgtg taccgttggg cgattagccg tgttcatcgt 360
gttgcgggtt gcccggaccc gtgcctggat atctatgtgg aggatcgtct gaaggcgatt 420
gcgcgtaaga aagtgcgtga gggcgaagcg gttaaacagg cgagcccgtt taacgaacaa 480
cacctgctga agctgaccag cctgtggtac cgtagcgaca aactgctgct gcgtcgtaac 540
ctggcgctgc tggcggtggc gtatgagagc atgctgcgtg cgagcgaact ggcgaacatc 600
cgtgttagcg acatggagct ggcgggtgat ggcaccgcga ttctgaccat cccgattacc 660
aagaccaacc acagcggcga gccggacacc tgcattctga gccaggatgt ggttagcctg 720
ctgatggact acaccgaagc gggcaagctg gacatgagca gcgatggttt cctgtttgtg 780
ggcgttagca aacacaacac ctgcatcaag ccgaagaaag ataaacagac cggtgaagtt 840
ctgcacaagc cgattaccac caaaaccgtg gagggcgttt tctatagcgc gtgggaaacc 900
ctggatctgg gtcgtcaagg cgtgaagccg tttaccgcgc acagcgcgcg tgttggtgcg 960
gcgcaggacc tgctgaagaa aggctacaac accctgcaaa tccagcaaag cggtcgttgg 1020
agcagcggcg cgatggttgc gcgttatggt cgtgcgatcc tggcgcgtga cggcgcgatg 1080
gcgcacagcc gtgtgaaaac ccgtagcgcg ccgatgcaat ggggcaagga cgagaaagat 1140
taa 1143
<210> 22
<211> 380
<212> PRT
<213> 人工序列
<220>
<223> VCre重组酶的氨基酸序列
<400> 22
Met Ile Glu Asn Gln Leu Ser Leu Leu Gly Asp Phe Ser Gly Val Arg
1 5 10 15
Pro Asp Asp Val Lys Thr Ala Ile Gln Ala Ala Gln Lys Lys Gly Ile
20 25 30
Asn Val Ala Glu Asn Glu Gln Phe Lys Ala Ala Phe Glu His Leu Leu
35 40 45
Asn Glu Phe Lys Lys Arg Glu Glu Arg Tyr Ser Pro Asn Thr Leu Arg
50 55 60
Arg Leu Glu Ser Ala Trp Thr Cys Phe Val Asp Trp Cys Leu Ala Asn
65 70 75 80
His Arg His Ser Leu Pro Ala Thr Pro Asp Thr Val Glu Ala Phe Phe
85 90 95
Ile Glu Arg Ala Glu Glu Leu His Arg Asn Thr Leu Ser Val Tyr Arg
100 105 110
Trp Ala Ile Ser Arg Val His Arg Val Ala Gly Cys Pro Asp Pro Cys
115 120 125
Leu Asp Ile Tyr Val Glu Asp Arg Leu Lys Ala Ile Ala Arg Lys Lys
130 135 140
Val Arg Glu Gly Glu Ala Val Lys Gln Ala Ser Pro Phe Asn Glu Gln
145 150 155 160
His Leu Leu Lys Leu Thr Ser Leu Trp Tyr Arg Ser Asp Lys Leu Leu
165 170 175
Leu Arg Arg Asn Leu Ala Leu Leu Ala Val Ala Tyr Glu Ser Met Leu
180 185 190
Arg Ala Ser Glu Leu Ala Asn Ile Arg Val Ser Asp Met Glu Leu Ala
195 200 205
Gly Asp Gly Thr Ala Ile Leu Thr Ile Pro Ile Thr Lys Thr Asn His
210 215 220
Ser Gly Glu Pro Asp Thr Cys Ile Leu Ser Gln Asp Val Val Ser Leu
225 230 235 240
Leu Met Asp Tyr Thr Glu Ala Gly Lys Leu Asp Met Ser Ser Asp Gly
245 250 255
Phe Leu Phe Val Gly Val Ser Lys His Asn Thr Cys Ile Lys Pro Lys
260 265 270
Lys Asp Lys Gln Thr Gly Glu Val Leu His Lys Pro Ile Thr Thr Lys
275 280 285
Thr Val Glu Gly Val Phe Tyr Ser Ala Trp Glu Thr Leu Asp Leu Gly
290 295 300
Arg Gln Gly Val Lys Pro Phe Thr Ala His Ser Ala Arg Val Gly Ala
305 310 315 320
Ala Gln Asp Leu Leu Lys Lys Gly Tyr Asn Thr Leu Gln Ile Gln Gln
325 330 335
Ser Gly Arg Trp Ser Ser Gly Ala Met Val Ala Arg Tyr Gly Arg Ala
340 345 350
Ile Leu Ala Arg Asp Gly Ala Met Ala His Ser Arg Val Lys Thr Arg
355 360 365
Ser Ala Pro Met Gln Trp Gly Lys Asp Glu Lys Asp
370 375 380
<210> 23
<211> 37
<212> DNA
<213> 人工序列
<220>
<223> 引物 17
<400> 23
aaggcgagga attctacgaa agtgccatat aacgcac 37
<210> 24
<211> 34
<212> DNA
<213> 人工序列
<220>
<223> 引物 18
<400> 24
gcgtcagttt accattagtt gcgtcacctt cacc 34
<210> 25
<211> 2298
<212> DNA
<213> 人工序列
<220>
<223> par 区域
<400> 25
atggatatca agctagccca ccccagcaag acgacgcctg aggatttgaa gcagttggca 60
aatctctccg cggtgatgct gcagaaaatt cgggatgaga tgctggagcc atttcctcgg 120
aaggaagccc cgctgatccc gtctggccgc ctacaagaat tgtgtggcat cgacaaaacg 180
cggatgaacc ggtccctcaa aaagggggat ctccctcagg gccagcaatc gcgacccggt 240
gcagtgcgct atttcagcct cagcgaggca atgcaatgga tccgagcgga acttaagcct 300
gtcccgcgaa ggggaccagg taaagtcatt gcagttgcga acttcaaggg cggtgtcacg 360
aagaccacta tgtccaccct cctctgccag ggcttgagtc tgcggcgagg tcggaaggtg 420
tgccacgttg atctggatcc gcagggaagc gcaaccacgc tgtatggcat caatccacat 480
gccgaggtgt cgtccgaaaa caccattatg ccgctcatcg aggcgtattt ggcgggcgag 540
tccttcgata tgcgagggct tcctcaggag acttactggc ctaacctgga tttgattcct 600
tcgtctactg agcttttcaa cgcggagttt atgcttccgg ctcgggcgac ggcagaggaa 660
ggccatattc cgttcgagcg cgtgttaagt aacggcctcg attcgttgaa agacgaatat 720
gactacatca tcctcgacac ggctcctacc ctcagctacc tgaccatcaa cgcgattttc 780
gctgccgatg gcgtcatcgt accggtggtc ccggacacct tggctttcgc gtctatggtc 840
cagttctggc aactcttctc ggacctagta acaggcatgg aagagcagag cgagggatct 900
aaaaaggagt tcgactttct cgatgttctc atgacacgca tggagaaaaa gaacgctcct 960
cgcctggtgg cagactggat tcgcggcgtc tatgggtcgc gcgtgctgcc gattgagatc 1020
cctgagacgg acctcgcccg taacagcagc attcaatttc gcacggtcta tgacctctcc 1080
tctagcgagg cgaacaccga gacgatgcga cgcattcgcc aaccctgcga tgagtttgtc 1140
gactatgtgg acgacaaggt cagcgcgctt tggcaaggaa ttgaagaatg agtttgagag 1200
aaaagcttgc cgcaaaggct gggaacatca aggtcacggc ggaagacttg gagaaagccg 1260
ctgcgcgcgg tccgcaagcg ccgcgaactg cgcccggtca gttaatgcat atgcaaggga 1320
aggttgagcg acaggctaac gagatcgcgc aactaagagc agaacttgag tcggcccgcg 1380
tcagcggcgg cgcagtggat gtgcctatcg accaactgca tgaggtccca ggccgcagac 1440
gcttcatgcc tcccgagaag tatgtcgaat tgagggaaaa cctcaggcac aacaagctcg 1500
ttcatcctgt gattgtatgc cctcggcctg cgggaggctt cgagattgtc tccgggcatc 1560
accggacaga cgcgtaccgc gagcttgggc gcgatcacat acgctgcgtg ctcggcgaac 1620
ttagttcaga cgaggctgac acgggcgcgt tctacgcgaa ccttatgcag tcagatttaa 1680
cggatttcga gaagtttcgg aagttcgacg aactgctgct tcgcagccca gacaagactc 1740
aagccgcaat agctgaacag gctggtgtac ctgtctcgac tctctcagag attttgtcgt 1800
tccggaactt gcctcccgag gtcctaagcc ttctcgatag ccgcccagac ctgctcgggt 1860
cgaatgctgg cgccgagttg gcaagggcga ccaaagacgg tcgcggggat cgggtcgtcg 1920
aagcggttaa gttgttggcc gagaagaaga tcgatcaaca gcaggccgta cggatgacta 1980
aggccgagca ggttaagacc aggcctgccg catctaccgg cttcaaaatc aaggcgggaa 2040
aggcgacttg gtgcgatgtt cgtatcgcaa agaaagtcat gcgcattgag ttccgcagcg 2100
aggaagaagc ggaagcggcc caatcggcca ttcgcgaaca tctggaaggg ttagctaaag 2160
ctgcgtcgga agacgcaaaa agctaagtgc ttgtttttta aggacttcgt actacgaatc 2220
gaggttttaa gccatgtcta gactgtaatc ctacaaaaac aaaagcccac ggcggcaacc 2280
gtgggctttt gagaactt 2298
<210> 26
<211> 92
<212> DNA
<213> 人工序列
<220>
<223> 复制蛋白 repA28
<400> 26
ggtcttgatg taaatttaat tttttggttg atgcgaaagg ctaaagagca aggccacttt 60
ctctcagatg tcgtaagcgc gacatgggag ag 92
Claims (10)
1.一种删除稳定载体上冗余片段的方法,所述方法包括以下步骤:
1)将稳定载体导入罗氏真养菌中获得转化体,其中,所述稳定载体中的所述冗余片段的上游和下游各有1个重组酶特异性识别的核苷酸序列,并且所述稳定载体包含par区域中的启动子parP、质粒稳定化因子parA、parB、识别序列parS,复制蛋白repA,以及所述冗余片段,优选地,所述par区域的核苷酸序列包含如SEQ ID No.:25所示的序列;
2)向所述转化体中导入表达所述重组酶的帮助质粒,经重组实现所述冗余片段的删除。
2.根据权利要求1所述的方法,其中,所述重组酶选自VCre重组酶、Bxb1重组酶、phiC31重组酶、TP901重组酶、HK022重组酶、Phi80重组酶、P21重组酶、Int3重组酶、Int4重组酶、Int5重组酶、Int9重组酶、Int11重组酶、Int12重组酶、Int13重组酶、P22重组酶、lamda重组酶、Cre重组酶、Dre重组酶、Vika重组酶、Flp重组酶、FimE重组酶、HbiF重组酶、A118重组酶中。
3.根据权利要求1所述的方法,其中,所述重组酶特异性识别的核苷酸序列为VloxP序列,所述重组酶为VCre重组酶。
4.根据权利要求1所述的方法,其中,所述罗氏真养菌是Ralstonia eutropha H16。
5.根据权利要求1所述的方法,其中,所述冗余片段包括抗性基因,优选地,所述抗性基因是抗生素抗性基因,更优选地,所述抗性基因是卡那霉素抗性基因。
6.根据权利要求5所述的方法,其中,所述冗余片段还包括大肠杆菌复制子。
7.一种通过如权利要求1至6中任一项所述的方法得到的稳定载体。
8.如权利要求7所述的稳定载体在基因工程中的应用。
9.如权利要求7所述的稳定载体用于罗氏真养菌中的应用。
10.一种罗氏真养菌重组菌,其包含如权利要求7所述的稳定载体。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010850010.XA CN113355346A (zh) | 2020-08-21 | 2020-08-21 | 删除稳定载体上冗余片段的方法,采用该方法得到的稳定载体及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010850010.XA CN113355346A (zh) | 2020-08-21 | 2020-08-21 | 删除稳定载体上冗余片段的方法,采用该方法得到的稳定载体及其应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113355346A true CN113355346A (zh) | 2021-09-07 |
Family
ID=77524443
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010850010.XA Pending CN113355346A (zh) | 2020-08-21 | 2020-08-21 | 删除稳定载体上冗余片段的方法,采用该方法得到的稳定载体及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113355346A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114381415A (zh) * | 2022-03-22 | 2022-04-22 | 深圳蓝晶生物科技有限公司 | 高产pha的基因重组菌及其构建方法 |
CN116288740A (zh) * | 2023-05-11 | 2023-06-23 | 北京蓝晶微生物科技有限公司 | 一种微生物启动子库及其应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101297036A (zh) * | 2005-10-27 | 2008-10-29 | 株式会社钟化 | 新质粒载体和稳定保持质粒的转化体 |
CN103409446A (zh) * | 2013-05-31 | 2013-11-27 | 江南大学 | 一种棒状杆菌基因连续敲除系统及其构建方法和应用 |
-
2020
- 2020-08-21 CN CN202010850010.XA patent/CN113355346A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101297036A (zh) * | 2005-10-27 | 2008-10-29 | 株式会社钟化 | 新质粒载体和稳定保持质粒的转化体 |
CN103409446A (zh) * | 2013-05-31 | 2013-11-27 | 江南大学 | 一种棒状杆菌基因连续敲除系统及其构建方法和应用 |
Non-Patent Citations (1)
Title |
---|
柳杰 等: "微生物合成PHA的研究进展", 《高分子通报》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114381415A (zh) * | 2022-03-22 | 2022-04-22 | 深圳蓝晶生物科技有限公司 | 高产pha的基因重组菌及其构建方法 |
CN116288740A (zh) * | 2023-05-11 | 2023-06-23 | 北京蓝晶微生物科技有限公司 | 一种微生物启动子库及其应用 |
CN116288740B (zh) * | 2023-05-11 | 2023-08-29 | 北京蓝晶微生物科技有限公司 | 一种微生物启动子库及其应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2443163T3 (en) | POLYMERIZATION OF ISOPREN FROM RENEWABLE RESOURCES | |
KR20110038087A (ko) | 재생가능 자원으로부터의 이소프렌 중합체 | |
KR20110122672A (ko) | 이소프렌 및 공-산물을 제조하는 방법 | |
CN106906175A (zh) | 用于生产尸胺的方法和重组微生物 | |
TW201120204A (en) | Fuel compositions comprising isoprene derivatives | |
CN113355346A (zh) | 删除稳定载体上冗余片段的方法,采用该方法得到的稳定载体及其应用 | |
KR20100118973A (ko) | 이소프렌을 생성하기 위한 조성물 및 방법 | |
US7943377B2 (en) | Process for plasmid DNA fermentation | |
KR20110076868A (ko) | 분리 조건 및/또는 안전한 작업 범위 하에서의 c5 탄화수소가 없는 이소프렌의 제조 방법 및 조성물 | |
JPS63159397A (ja) | 組換えb型肝炎ウィルス抗原 | |
JPH0138475B2 (zh) | ||
AU5252498A (en) | Improved expression vectors | |
CN101395282A (zh) | 启动子改造与遗传控制 | |
TW200530398A (en) | P EF-TU expression units | |
Miwa et al. | Construction of L-threonine overproducing strains of Escherichia coli K-12 using recombinant DNA techniques | |
CN113502254B (zh) | 橄榄醇合成酶变体和表达其的工程化微生物 | |
CN113355345B (zh) | 一种基因组整合外源序列的方法 | |
CN113502255B (zh) | 用于生产橄榄醇和橄榄醇酸的工程化微生物 | |
CN106929528B (zh) | 假单胞菌中新型重组系统及其应用 | |
CA2509702A1 (en) | Mutations affecting plasmid copy number | |
WO2024206940A1 (en) | Engineered cssdna production hosts and phagemids | |
EP4379058A1 (en) | Biomineralization vector and transformant for transformation of chlorella vulgaris | |
CN114703171B (zh) | 酯酰辅酶a合成酶变体及其工程化微生物 | |
JPS6158595A (ja) | 徴生物によるタンパク質規模生産方法 | |
EP0437579B1 (en) | Enhancement of naphthalene dioxygenase activity during microbial indigo production |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210907 |
|
RJ01 | Rejection of invention patent application after publication |